A detailed history of Stifel Financial Corp transactions in Biolife Solutions Inc stock. As of the latest transaction made, Stifel Financial Corp holds 12,988 shares of BLFS stock, worth $355,741. This represents 0.0% of its overall portfolio holdings.

Number of Shares
12,988
Previous 12,318 5.44%
Holding current value
$355,741
Previous $263,000 23.57%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$19.19 - $26.52 $12,857 - $17,768
670 Added 5.44%
12,988 $325,000
Q2 2024

Aug 13, 2024

BUY
$15.14 - $22.99 $186,494 - $283,190
12,318 New
12,318 $263,000
Q1 2021

May 14, 2021

SELL
$32.95 - $44.24 $398,101 - $534,507
-12,082 Closed
0 $0
Q4 2020

Feb 12, 2021

SELL
$27.5 - $45.75 $12,595 - $20,953
-458 Reduced 3.65%
12,082 $482,000
Q3 2020

Nov 16, 2020

BUY
$16.04 - $28.94 $201,141 - $362,907
12,540 New
12,540 $363,000

Others Institutions Holding BLFS

About BIOLIFE SOLUTIONS INC


  • Ticker BLFS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 42,684,400
  • Market Cap $1.17B
  • Description
  • BioLife Solutions, Inc. develops, manufactures, and supplies bioproduction tools and services for the cell and gene therapy industry in the United States, Canada, Europe, the Middle East, Africa, and internationally. The company's products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies. It of...
More about BLFS
Track This Portfolio

Track Stifel Financial Corp Portfolio

Follow Stifel Financial Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Stifel Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Stifel Financial Corp with notifications on news.